In addition, cell viability was evaluated after inhibition of cyclin D1 expression by small-molecule inhibitors 4-CPA or CyP (Figure S2), which have been demonstrated to inhibit CCND1 promoter activity and breast cancer cell growth [20, 21]. This evidence concerns the gene CCND1 and breast carcinoma.